MedPath

NAPROSYN SUS 25MG/ML

NAPROSYN SUS 25MG/ML

Discontinued
DIN Number

00587923

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

syntex inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00587923
AIG Number0109634006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXENActive
Strength: 25 MG / ML
Monograph: NAPROXEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.